174 related articles for article (PubMed ID: 36608868)
1. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.
Cao Y; Di X; Cong S; Tian C; Wang Y; Jin X; Zhao M; Zhou X; Li R; Wang K
Life Sci; 2023 Feb; 315():121359. PubMed ID: 36608868
[TBL] [Abstract][Full Text] [Related]
2. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
4. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung Cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract][Full Text] [Related]
5. METTL3-Mediated m
Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
[TBL] [Abstract][Full Text] [Related]
6. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
Li D; Fu Z; Dong C; Song Y
Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
[TBL] [Abstract][Full Text] [Related]
7. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
8. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
Zhang Y; Xu Y; Qiu G; Luo Y; Bao Y; Lu J; Wang T; Wang Y
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37897586
[TBL] [Abstract][Full Text] [Related]
9. RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC.
Cong S; Di X; Li R; Cao Y; Jin X; Tian C; Zhao M; Wang K
Cancer Cell Int; 2022 Nov; 22(1):338. PubMed ID: 36335386
[TBL] [Abstract][Full Text] [Related]
10. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
11. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
[TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
13. Methyltransferase-like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway.
Cheng FW; Peng LM; Luo D
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):748-758. PubMed ID: 35434840
[TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
15. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
16. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
18. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
19. ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway.
Li F; Gu F; Li Q; Zhai C; Gong R; Zhu X
J Biochem Mol Toxicol; 2021 May; 35(5):e22726. PubMed ID: 33491326
[TBL] [Abstract][Full Text] [Related]
20. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]